Printer Friendly

Microplate agglutination test for canine brucellosis using recombinant antigen-coated beads.

1. Introduction

Brucellosis is one of the world's major bacterial zoonosis and an important cause of a serious debilitating disease in humans; further, it is the cause of abortion and sterility in animals. Brucella canis, a facultative, gram-negative, intracellular pathogen, is the etiologic agent of canine brucellosis [1]. Canine brucellosis is widely distributed around the world and this is an important disease due to the economic losses in animal production and its risks for human health [1]. Diagnosis of brucellosis is primarily based on bacteriological and serological tests [2]. Serological diagnosis is usually performed using a tube agglutination test (TAT), a rapid slide agglutination test, and a gel immunodiffusion test [2-4]. However, agglutination tests often give false positive results because of cross-reactions with other pathogens [2]. A general strategy for eliminating cross-reactions is to use purified antigen with unique epitopes in the serological tests. Bacterial cell wall antigens of B. canis can be prepared by hot saline extraction and are reportedly useful in serological diagnosis [5]. In a previous study, we reported the characterization of crude hot saline extracts and identified three antigens, namely, rhizopine-binding protein (RBP, former assigned ribose ABC transporter), Cu-Zn superoxide dismutase (SOD), and a hypothetical protein (Ag 4) [6].

This paper describes the development of latex beads coated with purified recombinant versions of these antigens and demonstrates the usefulness of these antigen-coated latex beads in the serological diagnosis of canine brucellosis.

2. Materials and Methods

2.1. Antigen Preparation. The gene encoding each antigen was amplified from chromosomal DNA isolated from B. canis [7] using PCR with the pair of primers shown in Table 1. The product was cloned into the pCold TF vector (Takara Bio Inc., Shiga, Japan). Trigger factor (TF) and His-tagged antigens were expressed in the Escherichia coli strain DH5a, and their purification was performed as described by the manufacturer (Novagen, Darmstadt, Germany) [8].

2.2. Canine Sera. Serum samples (n = 743) were collected from fleas- or ticks-infested dogs consecutively admitted to animal hospitals in Japan by the hospital staff in 2012 and 2013. B. canis-infected control sera were collected from three PCR-positive dogs, and B. canis-free control sera were collected from three specific pathogen-free (SPF) dogs [7].

2.3. Coating of Antigens onto Latex Beads. Covalent coupling of the proteins to carboxylated polystyrene latex beads was performed as described by the manufacturer (Polyscience Inc., Warrington, PA, USA). Briefly, equal volumes of antigen solution (protein concentration 300 [micro]g/mL, measured using Lowry method) and 2.5% latex beads (diameter 1 [micro]m, Polyscience Inc.) were mixed for 18 h at room temperature with stirring. Then, the latexbeads were blocked with 0.2 M borate buffer containing 0.25 M ethanolamine for 30 min at room temperature with stirring and were washed three times with 0.2 M borate buffer containing 1% bovine serum albumin. The latexbeads were then adjusted to a final concentration of 2.5% (w/v) with storage buffer and were maintained at 4[degrees]C.

2.4. Microplate Agglutination Test (MAT). This test was performed by mixing equal volumes (50 [micro]L) of latex bead solution and canine serum diluted 50-fold with PBS in each well of a 96-well round-bottom microwell plate (Nunc, Roskilde, Denmark) and incubating the plate at room temperature for 18 h without shaking. Samples showing agglutination were considered positive.

2.5. TAT. This test was performed by adding equal volumes (0.5 mL) of heat-inactivated B. canis QE-13 whole-cell antigens (optical density of 0.8 at 450 nm, Kitasato Laboratories, Saitama, Japan), with serum that had been serially diluted 2-fold with PBS, and incubating the mixture at 50[degrees]C for 24 h. Agglutination titers were determined from the final dilution of serum showing 50% agglutination. Titer of samples showing higher than 160 was considered positive [9].

2.6. SDS-PAGE and Western Blotting. The antigen solution was separated using 10% SDS-PAGE and then transferred to Immobilon-P membranes (Millipore, Billerica, MA, USA). The efficiency of transfer was determined using Coomassie brilliant blue R-250, and then the membranes were tested for reactivity with antibodies in the B. canis-infected control sera that were collected from three PCR-positive dogs [6, 8]. Immunoreactions were visualized using the enhanced chemiluminescence detection system (GE Healthcare Life Science, Little Chalfont, UK).

3. Results

3.1. Reactivity of Recombinant Antigens with Canine Sera. To test antigenic reactivity, four recombinant antigens were subjected to Western blotting along with the dog sera that had tested positive or negative in the TAT. All recombinant antigens showed strong reactivity with the positive sera, but not with the negative sera (Figure 1).

3.2. TAT. To identify B. canis-infected sera, we performed TAT on canine serum samples (n = 743) collected from dogs consecutively admitted to animal hospitals in Japan by the hospital staff. Antibodies to B. canis were detected in 9 of the 743 (1.2%) serum samples (Table 2). These TAT-positive sera did not show positive reaction in the PCR test.

3.3. MAT. Latex beads were coated with single or multiple recombinant B. canis antigens with the aim of achieving a serodiagnostic method that is faster and easier to perform. Sera from B. canis-infected dogs, in which infection had been confirmed by TAT and PCR previously, were mixed with the antigen-coated latex beads, and then this mixture was incubated at room temperature for 18 h. Agglutination was clearly observed in all antigens (Figure 2). In contrast, B. canis-free dog serum showed no agglutination (Figure 2). Various results were obtained when MAT was conducted using the 743 dog serum samples with each of the antigen-coated latex beads, as shown in Table 2. SOD reacted with 8 TAT-positive sera (88.9%), but RBP, Ag 4, and Hsp60 (heat shock protein 60) reacted with 6 (66.7%), 6 (66.7%), and 7 (77.8%) sera, respectively (Table 2). These antigens showed different reactivity in 4 of the 9 TAT-positive sera.

3.4. Elimination of False Positives by MAT. It is well known that hemolysis of serum samples induces false positive results in TAT [10]. To investigate if this source of false positive results is eliminated in the MAT, we performed the assay with antigen-coated latex beads using three artificial hemolytic sera from B. canis-free dogs. Indeed, hemolyzed serum showed a false positive result in TAT (Figure 3). In contrast, MAT with RBP-coated latex beads gave a negative result with the hemolyzed serum (Figure 3). The same results were obtained with latex beads coated with other antigens (data not shown).

4. Discussion

TAT and MAT, using whole B. canis antigens, are currently being used for serological diagnosis in dogs in Japan [11, 12]. However, nonspecific reactions occur in the serological diagnoses using whole bacterial cell antigens [13]. In a previous study, we reported a rapid slide agglutination test using latex beads that were coated with antigens extracted by hot saline for the serological diagnosis of canine brucellosis [6]. To develop a serological diagnosis method that is faster and easier to perform, we applied latex beads coated with crude antigens. However, we observed nonspecific reaction in MAT and, therefore, we used latexbeads coated with purified recombinant antigens in this study. Analysis of the antigens contained in the crude hot saline extracts, performed in our previous study, identified three antigens, namely, RBP, SOD, and Ag 4 [6]. Rhizopines are known to be nutritional mediators and play a role in nitrogen-fixing symbiotic associations between members of the Rhizobiaceae and legume plants [14]. Because B. canis is not a plant symbiont, the function of RBP of B. canis is completely unknown. In addition, the function of Ag 4 is currently unknown, and because SOD is a known antigenic protein of B. abortus [15], its potential value as a vaccine for brucellosis prevention and as a diagnostic reagent for the disease has been investigated [9, 16,17]. The results from our previous study also showed that recombinant SOD was useful for the detection of canine brucellosis using ELISA [8]. Hsp60 has also been known as an immunoreactive protein and virulence factor of B. abortus [18]. The present study showed that these four recombinant antigens can be used as a potential diagnostic marker for canine brucellosis. In particular, because the SOD antigen showed the highest reactivity to TAT-positive sera in the MAT, recombinant SOD maybe most useful for serological diagnosis. Usually, serum samples taken from dogs living in Japanese household do not show a positive result for PCR but sometimes show a positive result for TAT. We think bacteremia of Brucella may be rare case in dogs that are kept at home in Japan [6-8].

Hemolysis of serum samples affects serological diagnosis and induces false positive results. Although nonspecific agglutination shows a relationship with hemoglobin concentration [10], its detailed mechanism is still unclear. The purified recombinant antigen-coated latex beads developed in the present study will be useful tools for the serological diagnosis of canine brucellosis from hemolyzed serum specimens. Furthermore, MAT can be used for very small serum samples and offers potential for high throughput testing; therefore, it would be suitable for the screening of valuable samples such as those from wildlife or small animals. Moreover, conventional serological and bacteriological tests would be required to diagnose canine brucellosis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors' Contribution

Yussaira Castillo and Masato Tachibana investigators made an equal contribution to this work; they are co-first authors.


This work was supported by JSPS KAKENHI Grant no. 26850181.


[1] K. Nielsen and J. R. Duncan, Animal Brucellosis, CRC Press, Boca Raton, Fla, USA, 1990.

[2] R. Flores-Castro and L. E. Carmichael, "Canine brucellosis. Current status of methods for diagnosis," The Cornell Veterinarian, vol. 68, no. 7, pp. 76-88, 1978.

[3] L. W. George and L. E. Carmichael, "A plate agglutination test for the rapid diagnosis of canine brucellosis," The American Journal of Veterinary Research, vol. 35, no. 7, pp. 905-909, 1974.

[4] D. M. Myers, V. M. Varela Diaz, and E. A. Coltorti, "Comparative sensitivity of gel diffusion and tube agglutination tests for the detection of Brucella canis antibodies in experimentally infected dogs," Journal of Applied Microbiology, vol. 23, pp. 894-902, 1974.

[5] T. Serikawa, S. Iwaki, M. Mori, T. Muraguchi, and J. Yamada, "Purification of a Brucella canis cell wall antigen by using immunosorbent columns and use of the antigen in enzyme-linked immunosorbent assay for specific diagnosis of canine brucellosis," Journal of Clinical Microbiology, vol. 27, no. 5, pp. 837-842, 1989.

[6] M. Watarai, S. Kim, J. Yamamoto et al., "A rapid agglutination assay for canine brucellosis using antigen coated beads," The Journal of Veterinary Medical Science, vol. 69, no. 5, pp. 477-480, 2007

[7] S. Kim, D. S. Lee, H. Suzuki, and M. Watarai, "Detection of Brucella canis and Leptospira interrogans in canine semen by multiplex nested PCR," The Journal of Veterinary Medical Science, vol. 68, no. 6, pp. 615-618, 2006.

[8] G. Tsogtbaatar, M. Tachibana, K. Watanabe, S. Kim, H. Suzuki, and M. Watarai, "Enzyme-linked immunosorbent assay for screening of canine brucellosis using recombinant Cu-Zn superoxide dismutase," The Journal of Veterinary Medical Science, vol. 70, no. 12, pp. 1387-1389, 2008.

[9] J. Erdenebaatar, B. Bayarsaikhan, M. Watarai, S. Makino, and T. Shirahata, "Enzyme-linked immunosorbent assay to differentiate the antibody responses of animals infected with Brucella species from those of animals infected with Yersinia enterocolitica O9," Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 4, pp. 710-714, 2003.

[10] M. Kawaguchi, N. Saito, C. Katsukawa, and T. Soma, "Detection of anti-Brucella canis agglutination antibodies by microtiter and, study the effect of hemolysis," Journal of the Japan Veterinary Medical Association, vol. 64, pp. 957-961, 2011.

[11] M. Kimura, K. Imaoka, M. Suzuki, T. Kamiyama, and A. Yamada, "Evaluation of a Microplate Agglutination Test (MAT) for serological diagnosis of canine brucellosis," The Journal of Veterinary Medical Science, vol. 70, no. 7, pp. 707-709, 2008.

[12] T. Serikawa, T. Muraguchi, and N. Nakao, "A survey of dogs from Gifu and Shiga area for Brucella canis" Japanese Journal of Veterinary Science, vol. 39, no. 6, pp. 635-642,1977

[13] M. J. Corbel, "Recent advances in this study of Brucella antigens and their serological cross-reactions," Veterinary Bulletin, vol. 55, pp. 927-942, 1985.

[14] P. J. Murphy, W. Wexler, W. Grzemski, J. P. Rao, and D. Gordon, "Rhizopines-their role in symbiosis and competition," Soil Biology and Biochemistry, vol. 27, no. 4-5, pp. 525-529,1995.

[15] B. J. Bricker, L. B. Tabatabai, B. A. Judge, B. L. Deyoe, and J. E. Mayfield, "Cloning, expression, and occurrence of the Brucella Cu-Zn superoxide dismutase," Infection and Immunity, vol. 58, no. 9, pp. 2935-2939,1990.

[16] A. A. Onate, R. Vemulapalli, E. Andrews, G. G. Schurig, S. Boyle, and H. Folch, "Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus," Infection and Immunity, vol. 67, no. 2, pp. 986-988,1999.

[17] A. A. Onate, S. Cespedes, A. Cabrera et al., "A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice," Infection and Immunity, vol. 71, no. 9, pp. 4857-4861, 2003.

[18] M. Watarai, S. Kim, J. Erdenebaatar et al., "Cellular prion protein promotes Brucella infection into macrophages," The Journal of Experimental Medicine, vol. 198, no. 1, pp. 5-17,2003.

Yussaira Castillo, (1) Masato Tachibana, (1) Yui Kimura, (2) Suk Kim, (3) Yasuaki Ichikawa, Yasuyuki Endo, (5) Kenta Watanabe, (1,2) Takashi Shimizu, (1,2) and Masahisa Watarai (1,2)

(1) The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan

(2) Laboratory of Veterinary Public Health, Joint Faculty of Veterinary Medicine, 1677-1 Yoshida, Yamaguchi 753-8515, Japan

(3) Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea

(4) Merial Japan Limited, 3-20-2 Nishi Shinjuku, Shinjuku, Tokyo 163-1488, Japan

(5) Laboratory of Small Animal Internal Medicine, Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan

Correspondence should be addressed to Masahisa Watarai;

Received 30 May 2014; Revised 4 August 2014; Accepted 14 August 2014; Published 29 October 2014 Academic Editor: Konrad Trulzsch

TABLE 1: Primers used in this study.

Antigen       GenBank            Primers (5'-3')        Reference
          accession number

Hsp60        ABX63389.1      F: atggctgcaaaagacgtaaaa   This study
                             R: ttagaagtccatgccgcccat
RBP          ABX64027.1      F: atgttcaagaagggtatgcgc   This study
                             R: ttactgttccagaacgaacgg
SOD          ABX63876.1      F: atgaagtccttatttattgca      [16]
                             R: ttattcgatcacgccgcaggc
Ag 4         ABX61923.1      F: atgaccactggcatggatgac   This study
                             R: tcaatcctgcttcacctgacg

TABLE 2: Serological analysis of canine sera.

Antigen   tat+                        tat-

          9/743 (1.2%)                734/743 (98.8%)

             mat+           mat-       MAT+       mat-

Hsp60     7 (778% (a))    2 (22.2%)   0 (0%)   734 (100% (b))
RBP       6 (66.7% (a))   3 (33.3%)   0 (0%)   734 (100% (b))
SOD       8 (88.9% (a))   1 (11.1%)   0 (0%)   734 (100% (b))
Ag4       6 (66.7% (a))   3 (33.3%)   0 (0%)   734 (100% (b))

(a) Sensitivity; (b) specificity.
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Castillo, Yussaira; Tachibana, Masato; Kimura, Yui; Kim, Suk; Ichikawa, Yasuaki; Endo, Yasuyuki; Wat
Publication:International Scholarly Research Notices
Article Type:Report
Date:Jan 1, 2014
Previous Article:Ophthalmic manifestations of HIV patients in a rural area of Western Maharashtra, India.
Next Article:Prevalence of orthodontic treatment need and occlusal traits in schoolchildren.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters